ScoreWhy is Gilead Sciences, Inc. ?
1
High Management Efficiency with a high ROCE of 26.79%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.56 times
3
Strong Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 26.79%
4
Positive results in Dec 25
- ROCE(HY) Highest at 40.57%
- DIVIDEND PER SHARE(HY) Highest at USD 6.3
- RAW MATERIAL COST(Y) Fallen by -9.92% (YoY)
5
With ROCE of 52.14%, it has a very expensive valuation with a 7.97 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 29.39%, its profits have risen by 0.5% ; the PEG ratio of the company is 18.1
6
High Institutional Holdings at 89.94%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 1.52% over the previous quarter.
7
Market Beating performance in long term as well as near term
- Along with generating 29.39% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Gilead Sciences, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Gilead Sciences, Inc. for you?
Low Risk, High Return
Absolute
Risk Adjusted
Volatility
Gilead Sciences, Inc.
29.53%
3.83
29.18%
S&P 500
13.68%
0.71
19.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.61%
EBIT Growth (5y)
3.06%
EBIT to Interest (avg)
10.71
Debt to EBITDA (avg)
1.56
Net Debt to Equity (avg)
0.83
Sales to Capital Employed (avg)
0.70
Tax Ratio
12.60%
Dividend Payout Ratio
46.61%
Pledged Shares
0
Institutional Holding
89.94%
ROCE (avg)
26.79%
ROE (avg)
36.13%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
7.97
EV to EBIT
15.29
EV to EBITDA
13.00
EV to Capital Employed
7.97
EV to Sales
6.13
PEG Ratio
18.07
Dividend Yield
2.20%
ROCE (Latest)
52.14%
ROE (Latest)
44.10%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
ROCE(HY)
Highest at 40.57%
DIVIDEND PER SHARE(HY)
Highest at USD 6.3
RAW MATERIAL COST(Y)
Fallen by -9.92% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at 0 %
NET SALES(Q)
Highest at USD 7,925 MM
NET PROFIT(Q)
Highest at USD 3,162 MM
-8What is not working for the Company
INTEREST COVERAGE RATIO(Q)
Lowest at 1,162.35
DIVIDEND PAYOUT RATIO(Y)
Lowest at 45.4%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.86 times
OPERATING PROFIT(Q)
Lowest at USD 2,964 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 37.4 %
Here's what is working for Gilead Sciences, Inc.
Dividend per share
Highest at USD 6.3 and Grown
In each year in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (USD)
Net Sales
Highest at USD 7,925 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Profit
Highest at USD 3,162 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Net Profit
At USD 3,162 MM has Grown at 44.39%
over average net sales of the previous four periods of USD 2,189.84 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Debt-Equity Ratio
Lowest at 0 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -9.92% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Gilead Sciences, Inc.
Interest Coverage Ratio
Lowest at 1,162.35
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Profit
Lowest at USD 2,964 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at 37.4 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Inventory Turnover Ratio
Lowest at 1.86 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Dividend Payout Ratio
Lowest at 45.4%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
Non Operating Income
Highest at USD 0.17 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
